 |
Executive Summit: Emerging Strategic and Financial Issues
in the Pharmaceutical Industry
December 5, 2012
Yale Club, New York City
12:00 PM – 5:00 PM
Luncheon and Summit Co-Sponsored By:
|
Selected Topics and Speakers
Welcoming Comments
William Looney, Editor-In-Chief, Pharmaceutical Executive
Peter Young, President, Young & Partners
The
FDA: The Path Going Forward
Dr. Stephen P. Spielberg, Deputy Commissioner for Medical Products and Tobacco, The US Food and Drug Administration
The Pharmaceutical Industry Strategic and M&A Trends
Peter Young, President and Managing Director, Young & Partners
Perspectives on the Future of the Pharma Industry
Robert J. Hugin, Chairman, Chief Executive Officer, President, Celgene Corporation
The Pharmaceutical Market: Trends, Issues and Outlook
Doug Long, Vice President, IMS Health Inc.
The Increasing Clout of Personalized Medicine
John F. Crowley, Chairman & CEO, Amicus Therapeutics
Glenn A. Miller PhD, VP and Head of Personalized Healthcare and Biomarkers Strategy,
Portfolio and Alliances, AstraZeneca Pharmaceuticals
Biotech Deal Making – M&A, Licensing and Partnering Trends
Randolph Guggenheimer III, Managing Director, Young & Partners
By invitation only. This event is only for senior executives of pharma and biotech companies. It is not for service providers to the industry. To indicate your interest in applying for an invitation, please email your name, title, current company affiliation and contact information to secretary@youngandpartners.com. If you qualify as an industry senior executive, we will send you an invitation to attend as guests of the co-sponsors.
Young & Partners is an international investment banking firm focused on providing M&A and financing services to the pharmaceutical, biotech, medical device and diagnostic and chemical industries.
Pharmaceutical Executive is the leading magazine serving the needs of pharmaceutical executives.
|
|
|
